Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) Days Payable : 229.35 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Biocytogen Pharmaceuticals (Beijing) Co Days Payable?

Biocytogen Pharmaceuticals (Beijing) Co's average Accounts Payable for the six months ended in Dec. 2023 was HK$164.1 Mil. Biocytogen Pharmaceuticals (Beijing) Co's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$130.6 Mil. Hence, Biocytogen Pharmaceuticals (Beijing) Co's Days Payable for the six months ended in Dec. 2023 was 229.35.

The historical rank and industry rank for Biocytogen Pharmaceuticals (Beijing) Co's Days Payable or its related term are showing as below:

HKSE:02315' s Days Payable Range Over the Past 10 Years
Min: 259.27 Med: 325.49 Max: 369.43
Current: 259.27

During the past 4 years, Biocytogen Pharmaceuticals (Beijing) Co's highest Days Payable was 369.43. The lowest was 259.27. And the median was 325.49.

HKSE:02315's Days Payable is ranked better than
63.38% of 721 companies
in the Biotechnology industry
Industry Median: 149.7 vs HKSE:02315: 259.27

Biocytogen Pharmaceuticals (Beijing) Co's Days Payable declined from Dec. 2022 (312.12) to Dec. 2023 (229.35). It may suggest that Biocytogen Pharmaceuticals (Beijing) Co accelerated paying its suppliers.

Biocytogen Pharmaceuticals (Beijing) Co Days Payable Historical Data

The historical data trend for Biocytogen Pharmaceuticals (Beijing) Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocytogen Pharmaceuticals (Beijing) Co Days Payable Chart

Biocytogen Pharmaceuticals (Beijing) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Payable

369.43

319.03

331.94

280.82

Biocytogen Pharmaceuticals (Beijing) Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial			287.03	335.18	312.12	273.47	229.35

Competitive Comparison of Biocytogen Pharmaceuticals (Beijing) Co's Days Payable

For the Biotechnology subindustry, Biocytogen Pharmaceuticals (Beijing) Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocytogen Pharmaceuticals (Beijing) Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocytogen Pharmaceuticals (Beijing) Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Biocytogen Pharmaceuticals (Beijing) Co's Days Payable falls into.

Biocytogen Pharmaceuticals (Beijing) Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Biocytogen Pharmaceuticals (Beijing) Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (163.253	+	191.667)	/	2 )	/	230.654	*	365
=	177.46					/	230.654	*	365
=	280.82

Biocytogen Pharmaceuticals (Beijing) Co's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (136.592	+	191.667)	/	2 )	/	130.604	*	365 / 2
=	164.1295					/	130.604	*	365 / 2
=	229.35

Biocytogen Pharmaceuticals (Beijing) Co Days Payable Related Terms

Thank you for viewing the detailed overview of Biocytogen Pharmaceuticals (Beijing) Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

I54:Germany

Address

12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District, Beijing, CHN

Website

https://www.biocytogen.com.cn

Biocytogen Pharmaceuticals (Beijing) Co Ltd is a biopharmaceutical and pre-clinical research services company. It has two Core Products, YH003 and YH001. YH003 is a recombinant humanized agonistic anti-Cluster of Differentiation 40 (CD40) Immunoglobulin G2 (IgG2) monoclonal antibody and YH001 is a recombinant humanized anti-CTLA-4, a protein receptor expressed constitutively on T cells that functions as an immune checkpoint and downregulates immune responses, Immunoglobulin G1 (IgG1) monoclonal antibody. YH003 is being developed for pancreatic ductal adenocarcinoma, melanoma and other advanced solid tumors. YH001 is being developed for hepatocellular carcinoma (HCC), non-small-cell lung carcinoma (NSCLC) and other solid tumors.

Executives

Bvcf Realization Fund, L.p.	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Prowell Ventures Pte Ltd	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Gic Private Limited	2201 Interest of corporation controlled by you
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Yang Zhi	2201 Interest of corporation controlled by you
Innoveda Medtech, Ltd.	2201 Interest of corporation controlled by you
Ni Jian
Bvcf Realization Fund Gp, Ltd.	2201 Interest of corporation controlled by you
Bioveda China Fund Ii Rmb, Limited	2101 Beneficial owner
Cmbi Private Equity Series Spc	2201 Interest of corporation controlled by you
Cmb International Private Investment Limited	2201 Interest of corporation controlled by you
Cmb International Investment Management Limited	2201 Interest of corporation controlled by you

Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) Headlines

No Headlines